Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-20 of 37

Sort by

Sort Order Select

Journal Articles

Abstract 630: Directly engaging participants in rare cancer research is feasible: the osteosarcoma and leiomyosarcoma projects

Cancer Res (2025) 85 (8_Supplement_1): 630.

https://doi.org/10.1158/1538-7445.AM2025-630

Published: 21 April 2025

View articletitled, Abstract 630: Directly engaging participants in rare cancer research is feasible: the osteosarcoma and leiomyosarcoma projects

Journal Articles

Abstract PO2-09-03: Twenty-one gene recurrence scores in individuals with breast cancer associated with PALB2 germline pathogenic variants

Payal Shah, Siddhartha Yadav, Jamie Brower, Jada Hamilton, Erica Simmons, Judy Garber, Kenneth Offit, Mark Robson, Fergus Couch, Susan Domchek

Cancer Res (2024) 84 (9_Supplement): PO2-09-03.

https://doi.org/10.1158/1538-7445.SABCS23-PO2-09-03

Published: 02 May 2024

View articletitled, Abstract PO2-09-03: Twenty-one gene recurrence scores in individuals with breast cancer associated with PALB2 germline pathogenic variants

Journal Articles

Abstract PO5-26-11: The Breast Cancer Research Foundation Drug Research Collaborative – A unique and innovative model for industry-funded, academically driven research to advance the field of breast cancer

Unnati Jariwala, Dorraya El-Ashry, Judy Garber, Larry Norton

Cancer Res (2024) 84 (9_Supplement): PO5-26-11.

https://doi.org/10.1158/1538-7445.SABCS23-PO5-26-11

Published: 02 May 2024

View articletitled, Abstract PO5-26-11: The Breast Cancer Research Foundation Drug Research Collaborative – A unique and innovative model for industry-funded, academically driven research to advance the field of breast cancer

Journal Articles

Abstract PO5-22-10: Are contralateral prophylactic mastectomy rates impacted by ASBrS guidelines to offer germline genetic testing to all patients with breast cancer? Results from a large, prospective, single-institution cohort

Anna Weiss, Stephen Knapp, Danielle Braun, Brenna Barton, Monica McGrath, Samantha Stokes, Alison Laws, Laura Warren, Stefania Morganti, Filipa Lynce, Brittany Bychkovsky, Huma Rana, Dillon Davis, Jill Stopfer, Judy Garber, Tari King

Cancer Res (2024) 84 (9_Supplement): PO5-22-10.

https://doi.org/10.1158/1538-7445.SABCS23-PO5-22-10

Published: 02 May 2024

View articletitled, Abstract PO5-22-10: Are contralateral prophylactic mastectomy rates impacted by ASBrS guidelines to offer germline genetic testing to all patients with breast cancer? Results from a large, prospective, single-institution cohort

Journal Articles

Abstract PO3-08-08: Basal-Luminal (BL) Cells in Histologically Normal and Malignant Breast Tissue from BRCA1 and BRCA2 Carriers

Rodrigo Fonseca Abreu, Tabata Alves Domingos, Roberto Bonfim Pimenta Peixoto, Ashka Patel, Krishan Taneja, McKenna Moore, Alicia Pollaci, Judy Garber, Nomeda Girnius, Deborah Dillon

Cancer Res (2024) 84 (9_Supplement): PO3-08-08.

https://doi.org/10.1158/1538-7445.SABCS23-PO3-08-08

Published: 02 May 2024

View articletitled, Abstract PO3-08-08: Basal-Luminal (BL) Cells in Histologically Normal and Malignant Breast Tissue from BRCA1 and BRCA2 Carriers

Journal Articles

Abstract PO4-08-05: Disparities in Genetic Testing Patterns and Positivity Among Patients with Breast Cancer in the CancerLINQ Real-World Oncology Database

Olga Kantor, Alyssa Jones, Brittany Bychkovsky, Alison Laws, Anna Weiss, Huma Rana, Judy Garber, Rochelle Scheib, Marianna Chavez, Erica Mayer, Tari King, Elizabeth Mittendorf

Cancer Res (2024) 84 (9_Supplement): PO4-08-05.

https://doi.org/10.1158/1538-7445.SABCS23-PO4-08-05

Published: 02 May 2024

View articletitled, Abstract PO4-08-05: Disparities in Genetic Testing Patterns and Positivity Among Patients with Breast Cancer in the CancerLINQ Real-World Oncology Database

Journal Articles

Abstract B011: BRCA2 haploinsufficiency induces P53 degradation in primary mammary epithelial cells – a crucial early event in breast tumor promotion

Haohui Duan, Margaret Gillis, Deboral Dillon, Judy Garber, Shailja Pathania

Cancer Res (2024) 84 (3_Supplement_1): B011.

https://doi.org/10.1158/1538-7445.ADVBC23-B011

Published: 01 February 2024

View articletitled, Abstract B011: BRCA2 haploinsufficiency induces P53 degradation in primary mammary epithelial cells – a crucial early event in breast tumor promotion

Journal Articles

Abstract 6084: The Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network directly engage patient participants in genomics research

Cancer Res (2023) 83 (7_Supplement): 6084.

https://doi.org/10.1158/1538-7445.AM2023-6084

Published: 04 April 2023

View articletitled, Abstract 6084: The Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network directly engage patient participants in genomics research

Journal Articles

Abstract 5229: Pathogenic germline mutations and risk of multiple myeloma

Michael T. Conry, Nicola Camp, Celine Vachon, Michelle Hildebrandt, Elizabeth E. Brown, Steven M. Lipkin, Judy Garber, Susan L. Slager, Samantha Stokes, Aaron D. Norman, Aalin Izhar, Sita Dandiker, Kylee Maclachlan, Kenneth Offit, Saad Usmani, Vijai Joseph

Cancer Res (2023) 83 (7_Supplement): 5229.

https://doi.org/10.1158/1538-7445.AM2023-5229

Published: 04 April 2023

View articletitled, Abstract 5229: Pathogenic germline mutations and risk of multiple myeloma

Journal Articles

Abstract PD14-09: PD14-09 The effect of timing of TP53 genetic testing on treatment and outcomes among women with Li-Fraumeni syndrome and breast cancer

Renata Sandoval, Michele Bottosso, Natalia Polidorio, Brittany Bychkovsky, Benjamin Verret, Alessandra Gennari, Sophie Hyman, Maria Isabel Achatz, Olivier Caron, Fabrice Andre, Judy Garber

Cancer Res (2023) 83 (5_Supplement): PD14-09.

https://doi.org/10.1158/1538-7445.SABCS22-PD14-09

Published: 01 March 2023

View articletitled, Abstract PD14-09: PD14-09 The effect of timing of TP53 genetic testing on treatment and outcomes among women with Li-Fraumeni syndrome and breast cancer

Journal Articles

Abstract P5-14-03: Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study

Cancer Res (2023) 83 (5_Supplement): P5-14-03.

https://doi.org/10.1158/1538-7445.SABCS22-P5-14-03

Published: 01 March 2023

View articletitled, Abstract P5-14-03: Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study

Journal Articles

Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment

Brian Egleston, Mary Daly, Kaitlyn Lew, Lisa Bealin, Alexander Husband, Jill Stopfer, Pawel Przybysz, Olga Tchuvatkina, Yu-Ning Wong, Judy Garber, Timothy Rebbeck

Cancer Res (2023) 83 (5_Supplement): P5-03-16.

https://doi.org/10.1158/1538-7445.SABCS22-P5-03-16

Published: 01 March 2023

View articletitled, Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment

Journal Articles

Abstract P2-01-02: Clinicopathological characteristics, treatment patterns and disease outcomes of germline BRCA1/2 carriers with early stage HER2-negative breast cancer and potential eligibility for adjuvant Olaparib

Stefania Morganti, Qingchun Jin, Julie Vincuilla, Ryan Buehler, Sean Ryan, Samantha Stokes, Tonia Parker, Elizabeth A. Mittendorf, Tari King, Anna Weiss, Ann Partridge, Brittany Bychkovsky, Giuseppe Curigliano, Nabihah Tayob, Nancy U. Lin, Judy Garber, Sara Tolaney, Filipa Lynce

Cancer Res (2023) 83 (5_Supplement): P2-01-02.

https://doi.org/10.1158/1538-7445.SABCS22-P2-01-02

Published: 01 March 2023

View articletitled, Abstract P2-01-02: Clinicopathological characteristics, treatment patterns and disease outcomes of germline BRCA1/2 carriers with early stage HER2-negative breast cancer and potential eligibility for adjuvant Olaparib

Journal Articles

Abstract P6-02-08: Identifying preferences that may motivate choice of ovarian cancer risk prevention strategies using a discrete choice experiment

Mary Daly, Brian Egleston, Kaitlyn Lew, Lisa Bealin, Alexander Husband, Jill Stopfe, Pawel Przybysz, Olga Tchuvatkina, Yu-Ning Wong, Judy Garber, Timothy Rebbeck

Cancer Res (2023) 83 (5_Supplement): P6-02-08.

https://doi.org/10.1158/1538-7445.SABCS22-P6-02-08

Published: 01 March 2023

View articletitled, Abstract P6-02-08: Identifying preferences that may motivate choice of ovarian cancer risk prevention strategies using a discrete choice experiment

Journal Articles

Abstract P5-04-06: Breast Imaging Recommendations for Females <40 Years of Age with ≥20% Lifetime Breast Cancer Risk: Practice Patterns at a Specialized Clinic

Alexandra Wehbe, Alison Laws, Fisher Katlin, Eshita Sharma, Marybeth Hans, Mary Graichen, Brittany Bychkovsky, Rochelle Scheib, Judy Garber, Lydia Pace, Tari King

Cancer Res (2023) 83 (5_Supplement): P5-04-06.

https://doi.org/10.1158/1538-7445.SABCS22-P5-04-06

Published: 01 March 2023

View articletitled, Abstract P5-04-06: Breast Imaging Recommendations for Females <40 Years of Age with ≥20% Lifetime Breast Cancer Risk: Practice Patterns at a Specialized Clinic

Journal Articles

Abstract P3-04-03: The value of screening MRI in patients with high-risk breast lesions: An observational single-institution cohort study

Alison Laws, Fisher Katlin, Marybeth Hans, Mary Graichen, Olga Kantor, Christina Minami, Brittany Bychkovsky, Lydia Pace, Rochelle Scheib, Judy Garber, Tari King

Cancer Res (2022) 82 (4_Supplement): P3-04-03.

https://doi.org/10.1158/1538-7445.SABCS21-P3-04-03

Published: 15 February 2022

View articletitled, Abstract P3-04-03: The value of screening MRI in patients with high-risk breast lesions: An observational single-institution cohort study

Journal Articles

Abstract P2-11-21: Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model

Cancer Res (2022) 82 (4_Supplement): P2-11-21.

https://doi.org/10.1158/1538-7445.SABCS21-P2-11-21

Published: 15 February 2022

View articletitled, Abstract P2-11-21: Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model

Journal Articles

Abstract PD10-09: Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)

Shannon Gallagher, Elisha Hughes, Eric Rosenthal, Allison W. Kurian, Susan Domchek, Judy Garber, Braden Probst, Brian Morris, Placede Tshiaba, Benjamin Roa, Thomas P. Slavin, Susanne Wagner, Jeffrey N. Weitzel, Alexander Gutin, Jerry S. Lanchbury, Mark E. Robson

Cancer Res (2021) 81 (4_Supplement): PD10-09.

https://doi.org/10.1158/1538-7445.SABCS20-PD10-09

Published: 15 February 2021

View articletitled, Abstract PD10-09: Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)

Journal Articles

Abstract PD7-03: A living biobank of normal mammary organoids derived from patients at low and increased risk of developing breast cancer

Jennifer M Rosenbluth, Carman Man-Chung Li, Kenneth G Gray, Walter Gao, Ron CJ Schackmann, Jason J Zoeller, Laura M Selfors, Kaitlin Moore, Deborah Dillon, Judy Garber, Joan S Brugge

Cancer Res (2021) 81 (4_Supplement): PD7-03.

https://doi.org/10.1158/1538-7445.SABCS20-PD7-03

Published: 15 February 2021

View articletitled, Abstract PD7-03: A living biobank of normal mammary organoids derived from patients at low and increased risk of developing breast cancer

Journal Articles

Abstract LB-245: Validating models of imputing germline versus somatic status for variants detected by tumor-only genomic profiling using germline clinical testing data

Israel Gomy, Nahed Jalloul, Samantha Stokes, Alexander Gusev, Shridar Ganesan, Judy Garber, Hossein Khiabanian

Cancer Res (2020) 80 (16_Supplement): LB-245.

https://doi.org/10.1158/1538-7445.AM2020-LB-245

Published: 15 August 2020

View articletitled, Abstract LB-245: Validating models of imputing germline versus somatic status for variants detected by tumor-only genomic profiling using germline clinical testing data

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 630: Directly engaging participants in rare cancer research is feasible: the osteosarcoma and leiomyosarcoma projects

Abstract PO2-09-03: Twenty-one gene recurrence scores in individuals with breast cancer associated with PALB2 germline pathogenic variants

Abstract PO5-26-11: The Breast Cancer Research Foundation Drug Research Collaborative – A unique and innovative model for industry-funded, academically driven research to advance the field of breast cancer

Abstract PO5-22-10: Are contralateral prophylactic mastectomy rates impacted by ASBrS guidelines to offer germline genetic testing to all patients with breast cancer? Results from a large, prospective, single-institution cohort

Abstract PO3-08-08: Basal-Luminal (BL) Cells in Histologically Normal and Malignant Breast Tissue from BRCA1 and BRCA2 Carriers

Abstract PO4-08-05: Disparities in Genetic Testing Patterns and Positivity Among Patients with Breast Cancer in the CancerLINQ Real-World Oncology Database

Abstract B011: BRCA2 haploinsufficiency induces P53 degradation in primary mammary epithelial cells – a crucial early event in breast tumor promotion

Abstract 6084: The Osteosarcoma and Leiomyosarcoma Count Me In Projects of the Cancer Moonshot funded PE-CGS Network directly engage patient participants in genomics research

Abstract 5229: Pathogenic germline mutations and risk of multiple myeloma

Abstract PD14-09: PD14-09 The effect of timing of TP53 genetic testing on treatment and outcomes among women with Li-Fraumeni syndrome and breast cancer

Abstract P5-14-03: Clonal hematopoiesis of indeterminate potential after (neo)adjuvant chemotherapy versus endocrine therapy for early breast cancer: the CIRCE-eBC prospective cohort study

Abstract P5-03-16: Changes in preferences for ovarian cancer prevention strategies during the COVID-19 pandemic: Results of a discrete choice experiment

Abstract P2-01-02: Clinicopathological characteristics, treatment patterns and disease outcomes of germline BRCA1/2 carriers with early stage HER2-negative breast cancer and potential eligibility for adjuvant Olaparib

Abstract P6-02-08: Identifying preferences that may motivate choice of ovarian cancer risk prevention strategies using a discrete choice experiment

Abstract P5-04-06: Breast Imaging Recommendations for Females <40 Years of Age with ≥20% Lifetime Breast Cancer Risk: Practice Patterns at a Specialized Clinic

Abstract P3-04-03: The value of screening MRI in patients with high-risk breast lesions: An observational single-institution cohort study

Abstract P2-11-21: Integration of an ancestrally unbiased polygenic risk score with the Tyrer-Cuzick breast cancer risk model

Abstract PD10-09: Development of a breast cancer risk assessment model for ATM mutation carriers incorporating tyrer-cuzick and a polygenic risk score (PRS)

Abstract PD7-03: A living biobank of normal mammary organoids derived from patients at low and increased risk of developing breast cancer

Abstract LB-245: Validating models of imputing germline versus somatic status for variants detected by tumor-only genomic profiling using germline clinical testing data

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only